The Nintamed brand, founded in 2012 (Germany), from 20 sister brands and 2617 competing brands. The Nintamed brand is owned by DexCom, a company listed in New York. Nintamed belongs to the Medical Diagnostics & Research business sector.
Share price and profitability of the share DexCom (Nintamed)
Buy DexCom share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
DexCom
(Nintamed)
over 5 years*
USD 621.99
Stock market history DexCom (Nintamed)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
